1819.50SEK-0.52%Mkt Cap: 269.91B $P/E: 28.141d ago
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza,…
Industry Peers
Drug Manufacturers - Generalvs Drug Manufacturers - General
P/E
Pricier
P/B
Pricier
Div Yield
Higher
1M Perf
Avg
$1.07TUSDP/E 42.6
$611.36BUSDP/E 29.4
$444.21BUSDP/E 123.9
$308.01BUSDP/E 21.1
$317.37BUSDP/E 36.2
$281.52BUSDP/E 22.5
$275.65BUSDP/E 22.4
$202.85BUSDP/E 11.5
$195.44BUSDP/E 25.2
$156.86BUSDP/E 17.2
$137.24BUSDP/E 18.4
$117.66BUSDP/E 16.1
$97.68BUSDP/E 19.0
$86.27BUSDP/E 14.0
$51.69BUSD
$31.90BUSDP/E 23.3
MRV
Marvell Technology, Inc.$30.93BUSDP/E 11.7
$11.35BUSDP/E 22.7
$11.02BUSDP/E 19.1
$10.98BUSDP/E 19.1
$6.60BUSDP/E 14.6
$3.56BUSDP/E 14.6
$3.03BUSDP/E 18.5
$54.86MUSD
$39.77MUSD
ELXR
Elixxer Ltd.$9.51MUSD
FLXN
Horizon Flexible Income ETF—P/E 27.2
ROSE
DocMorris AG—
PHOO
Photocure ASA—
CELG-RI
Bristol-Myers Squibb Company Ce—
Indicators:|
Key Statistics
Company
Market Cap269.91B $
Enterprise Value273.52B $
Revenue (TTM)5.78B $
Gross Profit4.60B $
Net Income (TTM)978.04M $
Revenue/Share3.730 USD
Last Price1819.50 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees96.1K
CountrySE
SectorHealthcare
IndustryDrug Manufacturers - General
ISINGB0009895292
Valuation
P/E (Trailing)28.14
P/E (Forward)18.15
PEG1.40
EV/EBITDA142.79
EV/Revenue47.31
P/S47.05
P/B60.00
EPS (TTM)64.75
EPS (Forward)101.02
52W Range
1316.0083% of range1925.50
52W High1925.50 SEK
52W Low1316.00 SEK
Profitability
Gross Margin81.90%
Oper. Margin27.94%
EBITDA Margin33.13%
Profit Margin17.41%
ROE21.01%
ROA8.96%
Growth
Revenue Growth12.50%
Earnings Growth5.30%
Cash Flow & Leverage
Operating CF1.39B $
CapEx (TTM)564.83M $
FCF Margin10.85%
FCF Yield0.23%
Net Debt2.52B $
Net Debt/EBITDA1.32
Balance Sheet
Debt/Equity0.60
Current Ratio0.91
Quick Ratio0.70
Book Value/Sh30.56 SEK
Cash/Share4.955 SEK
Dividends
Fwd Div Rate29.62 SEK
Trail. Div Rate3.200 SEK
Div. Yield1.62%
5Y Avg Yield2.07%
Payout Ratio47.70%
Ex-Div DateFeb 19, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)1919.79 SEK
Upside (mean)+5.5%
Target Range1725.21 SEK – 2038.87 SEK
SEK1725.21+5.5% to meanSEK2038.87
# Analysts3
Ownership
Shares Out.1.55B
Float1.54B
Insiders0.05%
Institutions67.86%
Technical
SMA 501731.30 (+5.1%)
SMA 2001711.50 (+6.3%)
Beta0.21
S&P 52W Chg18.52%
Avg Vol (30d)284.00K
Avg Vol (10d)309.25K
Technical Indicators
RSI (14)64.2
MACD17.1108
MACD Signal0.0097
MACD Hist.+17.1011
BB Upper1827.27 SEK
BB Middle1720.67 SEK
BB Lower1614.08 SEK
BB Width12.39%
ATR (14)43.08 SEK
Vol Ratio (20d)0.85x